Products RotaTeq™ experimental formulation + RotaTeq™ existing formulation
RotaTeq™ experimental formulation + RotaTeq™ existing formulation Phase 3 Completed 0 watching 0 views this week📈 Rising Rotavirus Gastroenteritis
Rotavirus Gastroenteritis
Apr 29, 2013 → Mar 25, 2014
About RotaTeq™ experimental formulation + RotaTeq™ existing formulation RotaTeq™ experimental formulation + RotaTeq™ existing formulation is a phase 3 stage product being developed by Merck for Rotavirus Gastroenteritis. The current trial status is completed. This product is registered under clinical trial identifier NCT01600092. Target conditions include Rotavirus Gastroenteritis.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT01600092 Phase 3 Completed Apr 29, 2013 Mar 25, 2014 Rotavirus Gastroenteritis
Product Company Stage Hype Score Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP) Merck Phase 3 RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™ Merck Phase 3 Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered) Merck Phase 3 RotaTeq (V260) + IPV Merck Phase 3 Rotateq™ + Comparator: Placebo Merck Phase 3 RotaTeq™ (V260) + DTP-IPV Merck Approved Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + Placebo Merck Phase 1 Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo Merck Phase 3 V260 + Placebo to V260 + OPV + DTaP Merck Phase 3 rotavirus vaccine, live, oral, pentavalent + Placebo Merck Phase 3 Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo + Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo Merck Phase 1 Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: placebo + Comparator: Infanrix(tm) Hexa Merck Phase 3 Rotarix + RotaTeq Merck Phase 3 Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™) + Comparator: Comparator: Placebo (unspecified) Merck Phase 3
Other Products from Merck